ATE427740T1 - Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen - Google Patents

Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen

Info

Publication number
ATE427740T1
ATE427740T1 AT02795719T AT02795719T ATE427740T1 AT E427740 T1 ATE427740 T1 AT E427740T1 AT 02795719 T AT02795719 T AT 02795719T AT 02795719 T AT02795719 T AT 02795719T AT E427740 T1 ATE427740 T1 AT E427740T1
Authority
AT
Austria
Prior art keywords
sedating
antihistamine
compositions
release form
sedative
Prior art date
Application number
AT02795719T
Other languages
English (en)
Inventor
Mark Hirsh
Original Assignee
Collegium Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collegium Pharmaceutical Inc filed Critical Collegium Pharmaceutical Inc
Application granted granted Critical
Publication of ATE427740T1 publication Critical patent/ATE427740T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02795719T 2001-12-05 2002-12-03 Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen ATE427740T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/012,202 US6827946B2 (en) 2001-12-05 2001-12-05 Compositions containing both sedative and non-sedative antihistamines

Publications (1)

Publication Number Publication Date
ATE427740T1 true ATE427740T1 (de) 2009-04-15

Family

ID=21753834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795719T ATE427740T1 (de) 2001-12-05 2002-12-03 Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen

Country Status (9)

Country Link
US (2) US6827946B2 (de)
EP (1) EP1461015B1 (de)
JP (1) JP2005511711A (de)
AT (1) ATE427740T1 (de)
AU (1) AU2002360462A1 (de)
CA (1) CA2469369C (de)
DE (1) DE60231911D1 (de)
ES (1) ES2333308T3 (de)
WO (1) WO2003049680A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
ES2602730T3 (es) * 2003-09-24 2017-02-22 Novartis Consumer Health S.A. Comprimidos de diclofenaco revestidos
CA2550257A1 (en) * 2003-12-18 2005-07-07 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
JP2005325070A (ja) * 2004-05-14 2005-11-24 Ss Pharmaceut Co Ltd 睡眠改善剤
NL1026634C2 (nl) * 2004-07-12 2006-01-16 Willem Jacob Van Der Burg Psychofarmaceutisch preparaat en werkzame stof daarin.
US9592197B2 (en) * 2004-12-16 2017-03-14 Sovereign Pharmaceuticals, Llc Dosage form containing diphenhydramine and another drug
US20070003622A1 (en) * 2004-12-16 2007-01-04 Sovereign Pharmaceuticals, Ltd. Diphenhydramine containing dosage form
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US7529255B2 (en) * 2005-04-21 2009-05-05 Microsoft Corporation Peer-to-peer multicasting using multiple transport protocols
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
US20070253927A1 (en) * 2006-04-13 2007-11-01 Gwenaelle Jegou Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
NZ573173A (en) * 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption
WO2007143163A2 (en) * 2006-06-01 2007-12-13 Schering Corporation Pharmaceutical compositions for sustained release of phenyephrine
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
BRPI0719021A2 (pt) * 2006-11-21 2013-12-17 Mcneil Ppc Inc Suspensões analgésicas de liberação modificada.
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2704111C (en) * 2007-05-14 2017-06-20 Sustained Nano Systems Llc Hypercompressed particles for controlled release of ophthalmic medications
US20090148498A1 (en) * 2007-05-14 2009-06-11 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
EP2222299B1 (de) * 2007-11-19 2011-11-23 Bausch & Lomb Incorporated Verwendung von levocabastin zur modulierung der erzeugung von proinflammatorischen zytokinen
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009073216A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
NZ587202A (en) 2008-01-04 2013-03-28 Schabar Res Associates Llc Methods for measuring a patient response upon administration of a drug and compositions thereof
CA3066426A1 (en) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2009094457A2 (en) * 2008-01-22 2009-07-30 Auspex Pharmaceuticals Substituted benzhydrylethers
ES2910374T3 (es) 2009-03-17 2022-05-12 Nicox Ophthalmics Inc Formulaciones oftálmicas de cetirizina y procedimientos de uso
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
CA2754996A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法
CN103251591B (zh) * 2013-05-13 2014-12-17 中国科学院武汉病毒研究所 一种吡拉明马来酸盐在制备治疗或预防流感病毒药物中的应用
WO2014189933A1 (en) * 2013-05-22 2014-11-27 Empire Technology Development Llc Long delayed release laxative
AU2015317469B2 (en) 2014-09-19 2018-03-15 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
CN105527177B (zh) * 2016-01-11 2016-11-16 中国人民解放军理工大学 一种深部岩体爆炸地冲击扰动模拟试验方法及装置
US10064820B2 (en) * 2016-09-30 2018-09-04 Aptapharma Inc. Antihistamine compositions, combinations, and use thereof
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion
JP2020525549A (ja) 2017-06-27 2020-08-27 ハーモニクス エルエルシー 徐放性睡眠補助薬系
JP2020015690A (ja) * 2018-07-25 2020-01-30 ニプロ株式会社 レボセチリジン含有錠剤
JP7271869B2 (ja) * 2018-07-25 2023-05-12 ニプロ株式会社 レボセチリジン含有錠剤
CN110870864B (zh) * 2018-08-29 2021-09-24 复旦大学 马来酸卡比沙明在制备抗流感病毒药物中的应用
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
IL299845A (en) 2020-07-15 2023-03-01 Schabar Res Associates Llc Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2297599A (en) 1940-09-28 1942-09-29 Squibb & Sons Inc Effervescent tablet
GB800973A (en) 1954-08-13 1958-09-03 Sterling Drug Inc Improvements in or relating to pills or tablets
US4004036A (en) 1966-05-31 1977-01-18 Alberto Culver Company Effervescent molded triturate tablets
US3898323A (en) 1970-04-15 1975-08-05 Mirlin Corp Taste modifying composition
US3873727A (en) 1971-06-01 1975-03-25 Parke Davis & Co Stabilization of molded sublingual nitroglycerin tablets
US4139589A (en) 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
US4229447A (en) 1979-06-04 1980-10-21 American Home Products Corporation Intraoral methods of using benzodiazepines
CA1163561A (en) 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
CH647150A5 (de) 1980-01-21 1985-01-15 Wellcome Found Zubereitung, enthaltend ein tranquillans und ein propiophenon.
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB8430346D0 (en) 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
US4814181A (en) 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US5082667A (en) 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
US5021053A (en) 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
US5739136A (en) 1989-10-17 1998-04-14 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering medicaments
US5064656A (en) 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5156850A (en) 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
CA2104684A1 (en) 1991-03-04 1992-09-05 Mahdi B. Fawzi Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
JP2771911B2 (ja) 1991-08-09 1998-07-02 三菱電機株式会社 車載用ナビゲーション装置
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5248310A (en) 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5512293A (en) 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
DE59308333D1 (de) 1992-08-06 1998-05-07 Gergely Gerhard Leicht einnehmbare brausende Manteltablette
US5609884A (en) 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
DE69327328T2 (de) 1992-09-03 2000-06-21 Sepracor Inc., Marlborough Verwendund von norastemizol zur behandlung der allergischen rhinitis
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5368588A (en) 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5284298A (en) * 1993-04-13 1994-02-08 Fluid Controls Inc. Fluid-conducting swivel and method
CA2161217A1 (en) * 1993-04-30 1994-11-10 Carmelita Macklin Russell Coated pharmaceutical compositions
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5407339A (en) 1993-09-27 1995-04-18 Vector Corporation Triturate tablet machine
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5702723A (en) 1994-08-02 1997-12-30 Griffin; David Multi-stage delivery system for ingestible medications or nutrients
US5827180A (en) 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US5656284A (en) 1995-04-24 1997-08-12 Balkin; Michael S. Oral transmucosal delivery tablet and method of making it
US5558879A (en) 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5807579A (en) 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
US5900421A (en) 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
EP0914098B1 (de) 1997-05-30 2003-10-01 Osmotica Corp. Mehrlagige osmosevorrichtung
CN1159012C (zh) 1997-08-26 2004-07-28 阿旺蒂斯制药公司 用于组合哌啶子基烷醇-减充血剂的药物组合物
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
WO1999015173A1 (en) * 1997-09-19 1999-04-01 The Procter & Gamble Company Compositions and methods for treating respiratory disorders
FR2772615B1 (fr) 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
US6110500A (en) 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US6372254B1 (en) 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6051585A (en) 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6086914A (en) 1999-03-12 2000-07-11 Weinstein; Robert E. Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity
IE20000271A1 (en) 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
EP1231900A1 (de) 1999-11-23 2002-08-21 The Robert Gordon University Zweischichttabletten zur applikation in der mundhöhle enthaltend nicotin
DE19963319C2 (de) 1999-12-21 2002-02-14 Hennig Arzneimittel Gmbh & Co Orale pharmazeutische Zubereitung
EP1239859A2 (de) * 1999-12-21 2002-09-18 Schering Corporation Verwendung von desloratadine zur behandlung von entzündlicher und allergischer zustände in pädiatrische patienten
US6602518B2 (en) 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
EA005537B1 (ru) 2001-07-10 2005-04-28 Тева Фармасьютикал Индастриес Лтд. Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines

Also Published As

Publication number Publication date
WO2003049680A3 (en) 2003-10-30
US20050069580A1 (en) 2005-03-31
US6827946B2 (en) 2004-12-07
CA2469369A1 (en) 2003-06-19
ES2333308T3 (es) 2010-02-19
JP2005511711A (ja) 2005-04-28
EP1461015A2 (de) 2004-09-29
EP1461015B1 (de) 2009-04-08
US20030130263A1 (en) 2003-07-10
CA2469369C (en) 2008-11-18
DE60231911D1 (de) 2009-05-20
AU2002360462A1 (en) 2003-06-23
WO2003049680A2 (en) 2003-06-19
AU2002360462A8 (en) 2003-06-23
EP1461015A4 (de) 2007-07-25
US7585520B2 (en) 2009-09-08

Similar Documents

Publication Publication Date Title
DE60231911D1 (de) Sedierende und nicht sedierende antihistamine enthaltende zusammensetzungen
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
PT1326643E (pt) Inibicao do efeito emetico da metformina com antagonistas de receptores 5-ht3
GEP20084571B (en) Triazole derivatives as vasopressin antagonists
NO20052739L (no) CCR5-antagonister som medikamenter
AU2003242544A1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
MA27095A1 (fr) Formes de sels de e-2 -methoxy-n-(3-(4-(3-methyl-pyridine-3-yloxy)-phenylamino)-quinazoline-6-yl)-allyl)-acetamide, leur preparation et leur utilisation contre le cancer
WO2006031491A3 (en) Tricyclic anilide spirolactam cgrp receptor antagonists
NO20070336L (no) Indolderivater som histamin-reseptorantagonister
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
CO5590918A2 (es) Formulaciones
WO2007095091A3 (en) Oral delivery of therapeutic agents using tight junction agonists
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
ES2196898T3 (es) Antagonistas de receptores de crf y metodos relacionados.
WO2006070325A3 (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
UA83868C2 (ru) Производные бензимидазолона и хиназолинона в качестве агонистов человеческих рецепторов orl1
AR038824A1 (es) Composiciones de medicamentos que, junto a agentes colinergicos, contienen compuestos heterociclicos
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
WO2003082867A8 (en) Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
MXPA04008460A (es) Composiciones farmaceuticas de un inhibidor de pde4 o pde3/4 y un antagonista de receptor de histamina.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties